IL17A and rheumatoid arthritis: TNF-α also synergizes with IL-17 to stimulate inflammation in general, and studies in rheumatoid arthritis patients, in both ex vivo and gene expression experiments, showed that this results in increased levels of inflammatory mediators, higher levels of granulopoiesis and exacerbation of bone destruction by higher production of RANKL [17,18].